Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
109–144
Headlines
2175
Sources here
16
Companies here
20
Current section United States Medical Instruments & Supplies news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

BofA raises Merit Medical stock price target on growth outlook

BofA Securities has increased its price target for Merit Medical Systems (NASDAQ:MMSI) to $97 from $92, while maintaining a Neutral rating, citing confidence in the company's growth and margin outlook for 2026 and beyond. The firm's decision is based on an increased 2027 earnings …

MMSI main company
Sharemaestro market context Price above Trend Line 52 weeks +4.1% MMSI stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Staar Surgical (STAA) Surpasses Q2 Earnings and Revenue Estimates

Staar Surgical (STAA) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to a loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents …

STAA main company COO mentioned
Sharemaestro market context Trend signal active 52 weeks -14.7% · Next-week setup negative 43.8% STAA stored weekly price path from 15 Aug 2025 to 7 Aug 2026

STAAR Surgical (NASDAQ:STAA) Delivers Strong Q2 CY2026 Numbers But Stock Drops

STAAR Surgical (NASDAQ:STAA) reported strong Q2 CY2026 results, with revenue up 111% year-on-year to $93.54 million, exceeding analyst expectations, and GAAP EPS of $0.16, beating estimates by 12.6%. Despite these positive numbers, the stock dropped 8% immediately after the announcement. The company's operating margin …

STAA main company
Sharemaestro market context Trend signal active 52 weeks -14.7% · Next-week setup negative 43.8% STAA stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Align Technology (ALGN) Gund-related holders report 5.4% beneficial stake

A group of trusts and individuals related to the Gund family have reported a collective beneficial ownership of 5.4% in Align Technology (ALGN), totaling 3,812,981 shares out of 71,039,852 outstanding shares as of July 31, 2026. Key figures in this group, G. Zachary Gund …

ALGN main company
Sharemaestro market context Price below Trend Line 52 weeks +21.9% ALGN stored weekly price path from 15 Aug 2025 to 7 Aug 2026

ICU Medical (ICUI) CIO Ben Sousa sells 2,250 shares of common stock

ICU Medical Inc./DE's Chief Information Officer, Ben Sousa, reported the sale of 2,250 shares of common stock on August 12, 2026, at a price of $178.3152 per share. This transaction leaves him with 3,076 shares of directly held common stock. The sale was executed …

ICUI main company
Sharemaestro market context Trend signal active 52 weeks +52.6% ICUI stored weekly price path from 15 Aug 2025 to 7 Aug 2026

ICU Medical (ICUI) insider plans to sell 2,250 shares of common stock

An insider at ICU Medical, Inc. (ICUI) plans to sell 2,250 shares of common stock with an aggregate market value of $401,209.20 through Morgan Stanley Smith Barney LLC Executive Financial Services. These shares were acquired via equity compensation events, including restricted stock vesting in …

ICUI main company
Sharemaestro market context Trend signal active 52 weeks +52.6% ICUI stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Icu Medical Insider Sold Shares Worth $401,209, According to a Recent SEC Filing

An insider at ICU Medical (ICUI) sold shares valued at $401,209, as disclosed in a recent SEC filing. This transaction occurred on August 12, 2026, adding to previous insider sales announcements for the company. ICU Medical manufactures medical products for infusion therapy, vascular access, …

ICUI main company
Sharemaestro market context Trend signal active 52 weeks +52.6% ICUI stored weekly price path from 15 Aug 2025 to 7 Aug 2026

DENTSPLY SIRONA (XRAY) CFO awarded 104,200 stock options and 24,014 RSUs

DENTSPLY SIRONA (XRAY) EVP & CFO John C. Fortson was granted 24,014 Restricted Stock Units (RSUs) and 104,200 stock options. The RSUs and stock options vest in one-third annual increments over a three-year period, ending August 10, 2029. The stock options have an exercise …

XRAY main company
Sharemaestro market context Price above Trend Line 52 weeks -10.1% XRAY stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Earnings Flash (STAA) STAAR Surgical Company Reports Q2 Revenue $93.5M, vs. FactSet Est of $90.6M

STAAR Surgical Company (STAA) reported its Q2 revenue of $93.5 million, surpassing FactSet's estimate of $90.6 million. This financial update indicates a positive performance for the medical equipment company during the second quarter. The article provides a brief overview of the company's recent earnings.

STAA main company
Sharemaestro market context Trend signal active 52 weeks -14.7% · Next-week setup negative 43.8% STAA stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Insider Selling: Intuitive Surgical (NASDAQ:ISRG) Director Sells $4,000,000.00 in Stock

Intuitive Surgical director Gary Guthart sold 10,000 shares of company stock for $4 million at $400 per share under a pre-arranged Rule 10b5-1 trading plan. Despite a strong financial quarter with revenue up 18.4% and earnings beating estimates, investor concerns about slowing domestic procedure …

ISRG main company
Sharemaestro market context Price below Trend Line 52 weeks -21.1% · Next-week setup negative 40.2% ISRG stored weekly price path from 15 Aug 2025 to 7 Aug 2026

West Pharmaceutical (WST) CFO converts RSUs, withholds shares for taxes

West Pharmaceutical Services Inc.'s CFO, Robert W. McMahon, recently converted 7,149.205 restricted stock units (RSUs) into common stock. A portion of these shares, totaling 3,109.19, were withheld at a price of $351.37 per share to cover tax liabilities or exercise costs. This transaction, which …

WST main company
Sharemaestro market context Trend signal active 52 weeks +44.2% WST stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Morgan Stanley (ATR) discloses 3.23M AptarGroup shares in Schedule 13G/A

Morgan Stanley has filed an amended Schedule 13G/A, disclosing beneficial ownership of 3,232,550 shares of AptarGroup, Inc. common stock, which represents a 5.1% stake in the company as of June 30, 2026. The filing details shared voting power over 2,870,214 shares and shared dispositive …

ATR main company
Sharemaestro market context Price above Trend Line 52 weeks -1.3% ATR stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Is Bausch + Lomb’s Raised 2026 Outlook And Board Refresh Altering The Investment Case For BLCO?

Bausch + Lomb (BLCO) reported Q2 2026 revenue of US$1.39 billion and a reduced net loss of US$14 million, leading to a raised full-year 2026 revenue guidance of US$5.44 billion–US$5.54 billion. Concurrently, the company appointed four new directors to its board, aiming to enhance …

BLCO main company
Sharemaestro market context Price above Trend Line 52 weeks +15.3% BLCO stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Intuitive Surgical director Gary Guthart sells $4m in stock

Gary S. Guthart, a director at Intuitive Surgical Inc. (NASDAQ:ISRG), sold 10,000 shares of company stock for $4 million on August 11, 2026, under a pre-arranged trading plan. Following the sale, Guthart still directly holds over 1.2 million shares, with additional shares held indirectly …

ISRG main company
Sharemaestro market context Price below Trend Line 52 weeks -21.1% · Next-week setup negative 40.2% ISRG stored weekly price path from 15 Aug 2025 to 7 Aug 2026

ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?

Intuitive Surgical ISRG has faced a moderation in U.S. procedure growth during the first half of 2026, but management's commentary suggests the slowdown is more likely a temporary demand-timing issue than evidence of a structural deterioration. U.S. da Vinci procedures grew 12% in the …

ISRG main company
Sharemaestro market context Price below Trend Line 52 weeks -21.1% · Next-week setup negative 40.2% ISRG stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Maxim Group Maintains Bionano Genomics(BNGO.US) With Buy Rating, Maintains Target Price $4

Maxim Group has reiterated its Buy rating for Bionano Genomics (BNGO.US), along with a maintained target price of $4. This indicates a continued positive outlook from the firm regarding the company's stock performance and valuation.

BNGO main company
Sharemaestro market context Price below Trend Line 52 weeks -61.8% · Next-week setup negative 36.3% BNGO stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Teleflex Inc. stock outperforms competitors on strong trading day

Shares of Teleflex Inc. (TFX) increased by 2.08% to $136.32 on Wednesday, marking its second consecutive day of gains. This performance occurred on a mixed trading day where the S&P 500 Index rose by 0.26% and the Dow Jones Industrial Average fell by 0.04%.

TFX main company
Sharemaestro market context Trend signal active 52 weeks +12.8% TFX stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Intuitive Surgical (ISRG) director reports 10,000-share trust sale under 10b5-1 plan

Intuitive Surgical (ISRG) director Gary S. Guthart reported an indirect sale of 10,000 common shares by a trust on August 11, 2026, at $400.00 per share, under a Rule 10b5-1 trading plan. Following the transaction, the trust holds 1,245,679 shares, with additional indirect holdings …

ISRG main company
Sharemaestro market context Price below Trend Line 52 weeks -21.1% · Next-week setup negative 40.2% ISRG stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Two Years Of Growth Barely Change What You Pay For Intuitive Surgical

Photo by 127071 on Pixabay Consensus growth takes only a modest slice off the multiple, and the company has not yet set the instrument pricing that lands inside those two years. Intuitive Surgical (ISRG) trades at about $401.23, roughly 32% below its 52-week high …

ISRG mentioned
Sharemaestro market context Price below Trend Line 52 weeks -21.1% · Next-week setup negative 40.2% ISRG stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Solventum Corp. stock rises Wednesday, outperforms market

Solventum Corp. (SOLV) stock rose 1.41% to $85.29 on Wednesday, outperforming a mixed market session where the S&P 500 gained 0.26% and the Dow Jones Industrial Average fell 0.04%. The company's stock closed 5.23% below its 52-week high of $90.00.

SOLV main company
Sharemaestro market context Trend signal active 52 weeks +16.2% · Next-week setup negative 39.1% SOLV stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Baxter International Inc. stock underperforms Wednesday when compared to competitors

Baxter International Inc. (BAX) stock fell 2.39% to $26.95 on Wednesday, underperforming the broader market. This marked the second consecutive day of losses for the company, even as the S&P 500 Index rose 0.26% and the Dow Jones Industrial Average slightly declined by 0.04%.

BAX main company
Sharemaestro market context Trend signal active 52 weeks +14.9% · Next-week setup negative 42.6% BAX stored weekly price path from 15 Aug 2025 to 7 Aug 2026

National Vision Raises Outlook as Higher-Value Customers Fuel Breakout Quarter

By Karen Roman National Vision Holdings, Inc. (Nasdaq: EYE) said second quarter net revenue increased 2.5% to $498.8 million compared to the year prior and net income was $12.4 million against $8.7 million, with net income margin up to 2.5% from 1.8%. Diluted earnings …

WRBY mentioned
Sharemaestro market context Trend signal active 52 weeks -2.5% · Next-week setup negative 41.1% WRBY stored weekly price path from 15 Aug 2025 to 7 Aug 2026

The Bull Case For AptarGroup (ATR) Could Change Following Rising Sales, Softer EPS And Buybacks

AptarGroup (ATR) recently reported rising sales but softer net income and EPS for Q2 2026. Despite these mixed financial results, the company completed a significant share repurchase program and continues its dividend payments, indicating a consistent capital return strategy. This article suggests that while …

ATR main company
Sharemaestro market context Price above Trend Line 52 weeks -1.3% ATR stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Here's Why You Should Add BrightSpring Stock to Your Portfolio Now

BrightSpring Health Services, Inc. BTSG is well-poised for growth in the coming quarters, backed by strong momentum in Provider Services, expanding specialty and infusion operations, successful integration of acquired home health assets and a scalable home-based care platform. However, the Inflation Reduction Act (IRA)-related …

WST mentioned COO mentioned
Sharemaestro market context Trend signal active 52 weeks +44.2% WST stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Activist investor gets aggressive with offer to buy H.B. Fuller unit for more than $1B

Activist investor Ancora Holdings Group has publicly offered to buy H.B. Fuller's building adhesive solutions unit for $1.1 billion to $1.2 billion. This aggressive move comes after private discussions and expresses Ancora's frustration with H.B. Fuller's acquisition strategy, particularly its recent $943 million offer …

SOLV mentioned
Sharemaestro market context Trend signal active 52 weeks +16.2% · Next-week setup negative 39.1% SOLV stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Align says Chinese court ruled in its favour in Angelalign patent case

A Chinese court has issued a first-instance ruling in favor of Align Technology in its patent infringement case against Angelalign Technology. The court found that Angelalign infringed Align's patent related to closing extraction gaps using certain digital orthodontic treatment-planning technology and ordered Angelalign to …

ALGN main company
Sharemaestro market context Price below Trend Line 52 weeks +21.9% ALGN stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Federal Circuit Clarifies Priority Requirements for Prior Art in Dental Monitoring SAS v. Align Technology

The Federal Circuit Court of Appeals clarified the requirements for a U.S. patent publication to serve as prior art based on a provisional application's filing date in *Dental Monitoring SAS v. Align Technology, Inc.* The court ruled that for a patent to claim priority …

ALGN main company
Sharemaestro market context Price below Trend Line 52 weeks +21.9% ALGN stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Intuitive Surgical's Competitors Face Challenges That Limit Long-Term Appeal, Oppenheimer Says

Intuitive Surgical's (ISRG) competitors face unique workflow challenges and real estate issues that impact their long-term appeal, while customized price-volume contracts complicate competitors' return on investment and its flexible per-click model allows growth opportunities in Silver Upgrade to read this MT Newswires article and …

ISRG main company
Sharemaestro market context Price below Trend Line 52 weeks -21.1% · Next-week setup negative 40.2% ISRG stored weekly price path from 15 Aug 2025 to 7 Aug 2026

ALKS Stock Rises 27% in 3 Months: Here's What You Should Know

Shares of Alkermes ALKS have risen 26.5% in the past three months, driven by strong sales growth across its proprietary product portfolio and continued progress in its clinical pipeline. Alkermes' proprietary products include Vivitrol for alcohol and opioid dependence, Aristada for schizophrenia, Lybalvi for …

RGEN mentioned
Sharemaestro market context Trend signal started 52 weeks +31.8% RGEN stored weekly price path from 15 Aug 2025 to 7 Aug 2026

NPCE Q2 Earnings Beat Estimates on RNS Growth, '26 Revenue View Up

NeuroPace, Inc. NPCE reported a second-quarter 2026 loss per share of 18 cents, compared with a loss of 30 cents in the year-ago period. The figure beat the Zacks Consensus Estimate by 5.3%. Shares of NPCE were down approximately 2.3% during after-market trading following …

WST mentioned COO mentioned
Sharemaestro market context Trend signal active 52 weeks +44.2% WST stored weekly price path from 15 Aug 2025 to 7 Aug 2026

EMBECTA CORP. INVESTORS WITH LOSSES HAVE UNTIL AUGUST 17,

Bernstein Liebhard LLP reminds Embecta Corp. (NASDAQ: EMBC) investors that they have until August 17, 2026, to join a securities fraud class action lawsuit. The lawsuit alleges that Embecta made false and misleading statements about its business operations and financial stability between November 25, …

EMBC main company
Sharemaestro market context Price below Trend Line 52 weeks -66.4% · Next-week setup negative 44.0% EMBC stored weekly price path from 15 Aug 2025 to 7 Aug 2026

TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses

Tango Therapeutics TNGX incurred a loss of 37 cents per share in the second quarter of 2026, wider than the Zacks Consensus Estimate of a loss of 31 cents. The company had reported a loss of 35 cents per share in the year-ago quarter. …

RGEN mentioned
Sharemaestro market context Trend signal started 52 weeks +31.8% RGEN stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Anteris Technologies Global (NASDAQ:AVR) Shares Down 4.3% Following Weak Earnings

Anteris Technologies Global (NASDAQ:AVR) shares dropped 4.3% after reporting disappointing second-quarter earnings, missing analyst expectations for both EPS and revenue. The company reported a loss of $0.30 per share on $1.01 million in revenue, compared to estimates of a $0.21 loss and $1.50 million …

AVR main company
Sharemaestro market context Trend signal active 52 weeks +120.5% AVR stored weekly price path from 15 Aug 2025 to 7 Aug 2026

ALC Maintained by Mizuho -- Price Target Raised to $85.00

Mizuho has maintained an "Outperform" rating for Alcon (ALC) and raised its price target from $80.00 to $85.00, reflecting optimism about the company's growth potential. GuruFocus assesses ALC as 15.0% undervalued with a GF Value™ of $88.60 against its current price of $75.35, and …

ALC main company
Sharemaestro market context Price below Trend Line 52 weeks -17.2% · Next-week setup positive 55.9% ALC stored weekly price path from 15 Aug 2025 to 7 Aug 2026

UBS Adjusts Becton Dickinson and Co. PT to $205 From $190, Maintains Buy Rating

UBS has increased its price target for Becton Dickinson and Co. (BDX) to $205 from $190, while reiterating a "Buy" rating on the stock. This adjustment reflects a positive outlook from the analyst firm on the medical technology company. The article also lists recent …

BDX main company
Sharemaestro market context Price above Trend Line 52 weeks +17.6% · Next-week setup negative 32.1% BDX stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Intuitive Surgical (ISRG) Stock Has Plunged 33% in 2026. Here's Why One Fund Manager Remains Bullish -- and Why I Do, Too.

Key Points The robotic surgery specialist has over 12,000 installed systems globally. Right now, it's facing some headwinds, but it also has a lot going for it. The Baron Health Care Fund sees Intuitive Surgical as full of promise.10 stocks we like better than …

ISRG main company
Sharemaestro market context Price below Trend Line 52 weeks -21.1% · Next-week setup negative 40.2% ISRG stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context